Capricor Therapeutics | CAPR - Operating Expenses

Stock Price
29.88
Daily Change
1.01 3.48%
Monthly
7.12%
Yearly
126.67%
Q1 Forecast
28.23

Capricor Therapeutics reported $29.16M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 7.78M 3M Jun/2023
Bioline Rx USD 2.63M 24K Sep/2025
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Cipla INR 60.98B 1.06B Dec/2025
Cytokinetics USD 196.12M 27.43M Dec/2025
Geron USD 58.8M 2.31M Dec/2025
Grifols EUR 1.99B 217.4M Dec/2025
Immunic USD 25.73M 2.91M Sep/2024
J&J USD 18.97B 2.38B Dec/2025
Prothena USD 27.23M 14.95M Dec/2025
PTC Therapeutics USD 246.3M 38.78M Dec/2025
Sarepta Therapeutics USD 853.02M 390.78M Dec/2025